Answers are grounded in this paper and cite their sources.
AI-guided system improves operational efficiency and detects flow irregularities in pharmaceutical lines, highlighting its rule-based approach.
This scalable, non-invasive solution can be integrated into existing pharmaceutical lines to improve operational efficiency and product integrity. The rule-based approach offers interpretability, making it suitable for GMP-regulated environments. Across the operational validation set, the risk classifier achieved macro average precision 95.24%, recall 95.83%, and F1 95.21% .
No takes yet. Share an insight, caveat, or question.
Thattukolla et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: